GlassScriptPhysician profile
David Z Ascher
NPI 1205935749
$4,999.01
in general payments reported to CMS, 2019-2025
28 companies · $850 in 2025
The $850 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $262 · 2021: $524 · 2022: $1,025 · 2023: $1,418 · 2024: $637 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,905.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $517.29 | 2021-2025 | Krystexxa |
| Tactile Systems Technology INC | $404.25 | 2020-2025 | Nimbl, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $374.50 | 2022-2024 | Nuzyra |
| Kerecis Limited | $323.68 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $251.99 | 2022-2023 | Diamondback Peripheral |
| Organogenesis INC. | $250.00 | 2021 | |
| Horizon Therapeutics Plc | $248.71 | 2022-2023 | Krystexxa |
| Abbvie INC. | $239.89 | 2022-2024 | |
| Globus Medical, INC. | $170.31 | 2025 | Senza |
| Musculoskeletal Transplant Foundation INC. | $169.78 | 2022 | |
| Vaporox, INC. | $159.44 | 2023 | Vht-200 Wound Treatment Device |
| Aroa Biosurgery Incorporated | $153.21 | 2020 | |
| Reddress USA, INC. | $152.12 | 2023 | |
| Smith+Nephew, INC. | $140.00 | 2023 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl, Iodosorb Ointment 40g USA |
| Treace Medical Concepts, INC. | $135.48 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $131.94 | 2021 | |
| Averitas Pharma INC. | $130.00 | 2024 | Qutenza |
| Polynovo North America LLC | $127.13 | 2024 | Novosorb Btm |
| Leo Pharma INC. | $125.04 | 2023 | Adbry |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Vertex Pharmaceuticals Incorporated | $121.91 | 2025 | |
| Biotissue Holdings INC. | $110.58 | 2022 | |
| Wright Medical Technology, INC. | $97.89 | 2019 | |
| Kci USA, INC. | $96.34 | 2019 | |
| Sun Pharmaceutical Industries INC. | $89.29 | 2022 | |
| Orthofix Medical, INC. | $65.00 | 2022 | |
| Polarityte, INC. | $46.93 | 2019 | |
| Medtronic Vascular, INC. | $41.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ascher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.